Loading
From NewLimit's own hiring board · Oct 16, 2026
NewLimit is a biotechnology company working to radically extend human healthspan.
We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
Top roles Scientist, Metabolism ×3 · Scientist/Senior Scientist ×3 · Director / Senior Director, Clinical Operations ×1
Where South San Francisco, CA ×12
Folded from this feed's corpus only. No description of what NewLimit does, no rating.
Open roles 12